Technical Analysis for NLSP - NLS Pharmaceutics Ltd.

Grade Last Price % Change Price Change
F 3.34 1.52% 0.05
NLSP closed up 3.46 percent on Wednesday, November 20, 2024, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 1.52%
Wide Bands Range Expansion 1.52%
Oversold Stochastic Weakness 1.52%
NR7 Range Contraction 5.03%
Narrow Range Bar Range Contraction 5.03%
Lower Bollinger Band Walk Weakness 5.03%
Wide Bands Range Expansion 5.03%
Gapped Down Weakness 5.03%
Lower Bollinger Band Touch Weakness 5.03%
Oversold Stochastic Weakness 5.03%

   Recent Intraday Alerts

Alert Time
Down 3% about 4 hours ago
Down 2 % about 4 hours ago
Down 1% about 4 hours ago
10 DMA Resistance about 4 hours ago
Up 5% about 4 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neurological Disorders Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Drug Therapies Sleep Disorders Narcolepsy Amphetamine Methylphenidate Adhd Cataplexy Idiopathic Hypersomnia

Is NLSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.08
52 Week Low 3.0
Average Volume 266,806
200-Day Moving Average 7.43
50-Day Moving Average 4.59
20-Day Moving Average 3.80
10-Day Moving Average 3.56
Average True Range 0.47
RSI (14) 35.48
ADX 21.8
+DI 17.93
-DI 22.27
Chandelier Exit (Long, 3 ATRs) 3.77
Chandelier Exit (Short, 3 ATRs) 4.40
Upper Bollinger Bands 4.57
Lower Bollinger Band 3.02
Percent B (%b) 0.17
BandWidth 40.93
MACD Line -0.41
MACD Signal Line -0.38
MACD Histogram -0.0327
Fundamentals Value
Market Cap 117.36 Million
Num Shares 35.7 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -6.58
Price-to-Sales 0.00
Price-to-Book 4.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.95
Resistance 3 (R3) 3.96 3.76 3.84
Resistance 2 (R2) 3.76 3.59 3.75 3.80
Resistance 1 (R1) 3.52 3.48 3.64 3.51 3.77
Pivot Point 3.32 3.32 3.38 3.31 3.32
Support 1 (S1) 3.08 3.15 3.20 3.07 2.81
Support 2 (S2) 2.88 3.04 2.87 2.78
Support 3 (S3) 2.64 2.88 2.74
Support 4 (S4) 2.63